Clinical Trial Update: Intraperitoneal Chemotherapy Alone or in Combination With Bevacizumab for Ovarian Cancer With Peritoneal Adhesion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining intraperitoneal chemotherapy with or without bevacizumab for ovarian cancer with peritoneal adhesion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Peritoneal Adhesion | Phase 2 | Status: UNKNOWN